Robin Kramer insider trades

Open-market stock purchases and sales by Robin Kramer, Director at Armata Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 17, 2015.

Recent trades

DateStockTradeValue
Mar 9, 2026ARMP Armata Pharmaceuticals, IncBought (not open market)—
Feb 13, 2026BIIB Biogen IncBought (not open market)—
Feb 6, 2026BIIB Biogen IncSold (not open market)$54.9K
Feb 6, 2026BIIB Biogen IncSold (not open market)$41.6K
Feb 6, 2026BIIB Biogen IncBought (not open market)—
Feb 6, 2026BIIB Biogen IncSold (not open market)$214K
Feb 6, 2026BIIB Biogen IncBought (not open market)—
Feb 6, 2026BIIB Biogen IncBought (not open market)—

Companies traded

  • ARMP Armata Pharmaceuticals, Inc: other filings, last Mar 9, 2026
  • BIIB Biogen Inc: other filings, last Feb 13, 2026
  • HTZ Hertz Global Holdings, Inc: 2 sales, last Apr 29, 2018

Get free alerts when Robin Kramer files a new trade →